| Literature DB >> 28388950 |
Nikoo Safi1,2, Amin Haghani1,2, Shing Wei Ng1, Gayathri Thevi Selvarajah3, Farina Mustaffa-Kamal4, Abdul Rahman Omar1,3.
Abstract
BACKGROUND: There are two biotypes of feline coronavirus (FCoV): the self-limiting feline enteric coronavirus (FECV) and the feline infectious peritonitis virus (FIPV), which causes feline infectious peritonitis (FIP), a fatal disease associated with cats living in multi-cat environments. This study provides an insight on the various immune mediators detected in FCoV-positive cats which may be responsible for the development of FIP.Entities:
Keywords: Cytokine; Feline Coronavirus; Immune-mediators
Mesh:
Substances:
Year: 2017 PMID: 28388950 PMCID: PMC5384144 DOI: 10.1186/s12917-017-1019-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
TaqMan primers, MGB probes and accession numbers of the analyzed immune-related genes
| Gene | Primers sequences | MGB Probe | Accession number | Annealing temperature (°C) |
|---|---|---|---|---|
| CCL8 | 117CTTGCTCAGCCAGGTTCAGTT137 | 6FAMCCATCCCAATTACCTGCTMGBNFQ | XM_003996558 | 66 |
| Viperin | 219CCCCCACCAGCGTCAAC235 | 6FAMACCACTTCACCCGCCAGMGBNFQ | XM_003984516 | 60 |
| CXCL10 | 332ACACAGAAGCATAATCACCGTACTG356 | 6FAMCAAAGATGGACCAGAAAGMGBNFQ | XM_003985274 | 60 |
| MX1 | 469CAGGACTTTGAGACGGAGATTTC491 | 6FAMCCCTTCGGAGGTGGAMGBNFQ | XM_006935851 | 60 |
| CCL17 | 119GGGCCATCCCTCTCAGAAG137 | 6FAMTGACAGGGTGGTACAGGAMGBNFQ | NM_001009849 | 60 |
| GAPDHa | 71GTCCCCGAGACACGATGGT89 | 6FAMAAGGTCGGAGTCAACGGMGBNFQ | XM_006933438 | 57 |
Note: aReference gene
Intracellular FCoV load in CRFK cells at different time points post infection
| Time points (hpi) | FCoV copy number [Mean ± SEM (log10)] |
|---|---|
| Intracellular | |
| 0a | - |
| 3b | 5.22 ± 0.12 |
| 12d | 10.28 ± 0.06 |
| 24c | 6.33 ± 0.02 |
| 48f | 12.54 ± 0.34 |
| 72e | 11.83 ± 0.05 |
Note: Different alphabets indicate significant difference (p < 0.05) following Duncan post hoc analysis of three replicates from three independent experiments
Relative expression of immune-related genes following FIPV 79–1146 infection of CRFK cells
| Time points (hpi) | CCL8 (MCP2) | CXCL10 (IP10) | CCL17 | MX1 | Viperin (RSAD2) |
|---|---|---|---|---|---|
| 0 | 1 ± 0a | 1 ± 0a | 1 ± 0a | 1 ± 0a | 1 ± 0c |
| 3 | 21.67 ± 0.57d | 13,341.2 ± 197.75c | 39.68 ± 1.61e | 4.49 ± 0.62c | −13.04 ± 0a |
| 12 | 3.41 ± 0.07b | 8712.95 ± 343.29b | 3.56 ± 0b | 9.16 ± 1.27d | −7.82 ± 0.02b |
| 24 | 4.92 ± 0.04c | 1,835,241.44 ± 7662.16d | 22.87 ± 0.69d | 2.69 ± 0.11b | 5.72 ± 0.03d |
| 48 | 40,322.18 ± 14.38f | 8,569,241.92 ± 44,483.37e | 39.86 ± 0.6e | 900.72 ± 4.25f | 353.53 ± 1.82e |
| 72 | 21,651.02 ± 510.17e | 8,776,535.79 ± 30,986.02e | 8.51 ± 0.44c | 517.06 ± 5.38e | 583.3 ± 9.86f |
Note: Data are presented as means ± SEM of three replicates from two independent experiments. Different alphabets above the data indicate significant difference following Duncan post hoc comparison of each column (p < 0.05). Relative expression (ΔΔCq) was calculated by normalizing with the reference gene (GAPDH) and the negative controls
Measurement of immune-related protein concentrations (pg/ml) in FIPV 79–1146-infected CRFK cells at different time points
| Time points (hpi) | CXCL8 (IL8) | CXCL1 (KC) | CCL5 (RANTES) | CCL2 (MCP1) |
|---|---|---|---|---|
| 0 | 465.33 ± 2.14b | 9.23 ± 0.02a | 22.63 ± 0.27c | 913.03 ± 0.005a |
| 3 | 166.75 ± 25.74a | 28.55 ± 9.21b | 8.35 ± 0.004a | 960.84 ± 0.005b |
| 12 | 444.32 ± 3.03b | 8.32 ± 0.01a | 31.18 ± 0.61d | 923.22 ± 0.004a |
| 24 | 1564.5 ± 45c | 151.55 ± 9.98c | 16.75 ± 0.73b | 994.92 ± 7.38b |
| 48 | 1499.5 ± 82.34c | 119.02 ± 12.54c | 2470 ± 114.67f | 1068.5 ± 41.67c |
| 72 | 2551 ± 93.33d | 334.83 ± 9.49d | 126.6 ± 2.4e | 1050 ± 0.001c |
Note: Data are represented as means ± SEM of three replicates from two independent experiments. Different alphabets above the data indicate significant difference following Duncan post hoc comparison of each column (p < 0.05). Peak expression levels of the cytokines were detected at 48 and/or 72 hpi
Demographic and clinical features of the cats considered for this study
| ID | Age | Sex | Breed | FCoV titer | FELV /FIV titer | Body temperature °C | Peritoneal effusion | A:G ratio |
|---|---|---|---|---|---|---|---|---|
| 1 | 2–4 years | F | DSH | 0 | − | − | − | NA |
| 2 | 1 year | M | Persian | S2+ | − | N/A | − | 0.6 |
| 3 | 7 months | M | Persian | S3+ | − | N/A | − | NA |
| 6 | 8 months | F | DSH | S5+ | − | N/A | − | NA |
| 14 | 2 years | M | DSH | S5+ | − | N/A | − | NA |
| 15 | 2 years | F | DSH | S5+ | − | N/A | − | NA |
| 16 | 8 months | F | Persian | S5+ | − | 37.9 | − | 0.3 |
| 4 | 2 years | M | DSH | S3+ | − | N/A | + | NA |
| 7 | 7 months | M | Maine coon | S5+ | − | 37.3 | + | 0.3 |
| 8 | 9 months | M | DSH | S4+ | − | 39.2 | + | 0.4 |
| 9 | 3 years | M | DSH | S5+ | − | 38.6 | + | 0.6 |
| 5 | 2 years | M | DSH | S5+ | − | 39.8 | + | 0.3 |
| 10 | 8 months | M | DSH | S5+ | − | N/A | + | 0.3 |
| 11 | 10 months | M | Maine coon | S4+ | − | 40.5 | + | 0.3 |
| 12 | 1 year | M | Maine coon | S4+ | − | 38.3 | + | 0.5 |
| 13 | 11 months | M | Persian | S5+ | − | 40.0 | + | 0.4 |
Note: NA not available, DSH Domestic short hair, A:G Albumin/Globulin, F Female, M Male, FCoV scoring of S2+ titer low positive reaction, ≥S3+ titer positive reaction, ≥S5+ titer high positive reaction
Detection of FCoV load in plasma and supernatant of peritoneal effusion
| Cat status | Cat ID | FCoV copy number | |
|---|---|---|---|
| Plasma | PES | ||
| Negative controls | 1* | - a | - |
| Non effusive | 2 | 9.6 ± 0.05b | - |
| 3 | 10.73 ± 0.06cdefg | - | |
| 6 | 10.41 ± 0.82cde | - | |
| 14 | 10.25 ± 0.17c | - | |
| 15 | 10.53 ± 0.01cde | - | |
| 16 | 10.92 ± 0.34cdefgh | - | |
| Effusive | 4 | 11.06 ± 0.28efghi | N/A |
| 7 | 11.31 ± 0.33ghi | 14.16 ± 0.05l | |
| 8 | 10.74 ± 0.09cdefg | 13.01 ± 0.04k | |
| 9 | 11.72 ± 0.06ij | 12.13 ± 0.18j | |
| 5 | 11.28 ± 0.31fghi | 13.21 ± 0.05k | |
| 10 | 12.13 ± 0.35j | 10.6 ± 0.65cdef | |
| 11 | 10.99 ± 0.07defgh | 10.31 ± 0.09cd | |
| 12 | 11.57 ± 0.28hij | 11.69 ± 0.19ij | |
| 13 | 10.78 ± 0.74cdefg | 12.02 ± 0.05j | |
N/A not available, PES supernatant of peritoneal effusion
*Cat 1 represents three healthy cats as negative controls
Note: Data are presented as means ± SEM of three replicates. Different alphabets denote significant difference (p < 0.05) following Duncan post hoc analysis
Relative expression profiles of immune-related genes in PBMC of FCoV-positive cats
| Cat status | Cat ID | CCL8 (MCP2) | CXCL10 (IP10) | MX1 | Viperin (RSAD2) |
|---|---|---|---|---|---|
| Negative | 1* | ND | ND | ND | 1 ± 0bc |
| Non-effusive | 2 | ND | 18.67 ± 0.33b | 6.79 ± 1.8e | −1.88 ± 0.27bc |
| 3 | 16.32 ± 5.48c | ND | 0.91 ± 0.1cd | ND | |
| 6 | ND | ND | 0.03 ± 0a | −86.21 ± 0.01a | |
| 14 | 0.42 ± 0.02a | ND | 1.45 ± 0.36d | −28.01 ± 0.02b | |
| 15 | ND | ND | 0.58 ± 0.04c | −94.34 ± 0.01a | |
| 16 | ND | ND | 0.32 ± 0.07b | −39.84 ± 0.02b | |
| Effusive | 4 | ND | ND | 0.05 ± 0a | ND |
| 7 | 0.1 ± 0.05a | 0.23 ± 0.22a | 13.62 ± 5.07fg | 4.87 ± 1.39cd | |
| 8 | ND | ND | 3773.07 ± 67.71j | 437.28 ± 31.23f | |
| 9 | ND | ND | 7309.7 ± 52.55k | 50.48 ± 3.44e | |
| 5 | 1.08 ± 0.38b | 19.17 ± 0c | 19.14 ± 0.02gh | 4.95 ± 0.31cd | |
| 10 | ND | ND | 56.48 ± 13.47i | 7.91 ± 5.25de | |
| 11 | ND | ND | 6.79 ± 0.74ef | −3.35 ± 0.17c | |
| 12 | ND | ND | 16.37 ± 5.13g | 1.83 ± 0.45bcd | |
| 13 | ND | ND | 26.9 ± 1.61h | 10.16 ± 1.08de |
ND Not detected
*Average expression of three healthy cats as negative controls. Relative expression (ΔΔCq) was calculated by normalizing to the reference gene (GAPDH) and negative controls
Note: Data are presented as means ± SEM of three replicates. Different alphabets indicate significant difference following Duncan post hoc comparison of each column (p < 0.05)
Relative expression profiles of immune-related genes in cells from peritoneal effusion
| Cat ID | CCL8 (MCP2) | CXCL10 (IP10) | CCL17 | MX1 | Viperin (RSAD2) |
|---|---|---|---|---|---|
| 7 | 1.77 ± 0.29d | 2.14 ± 0e | 0.37 ± 0.19bc | 1.65 ± 0.09c | 2.14 ± 0e |
| 8 | 0.29 ± 0.06b | 0.57 ± 0.2bc | 18.95 ± 16.6cd | 11.24 ± 0.82e | 13.31 ± 1.98f |
| 9 | 0.46 ± 0.04bc | 0.36 ± 0.1b | 12.69 ± 6.01d | 0.58 ± 0.02b | 0.03 ± 0a |
| 5 | 0.12 ± 0.02a | 0.06 ± 0.01a | 0.37 ± 0.18cd | 0.61 ± 0.03b | 0.34 ± 0.02b |
| 10 | 1.43 ± 0.11d | 0.64 ± 0.1bcd | 0 ± 0a | 1.36 ± 0.1c | 0.79 ± 0.12c |
| 11 | 0.1 ± 0.04a | 0.85 ± 0.07cd | 9.18 ± 3.87d | 0.21 ± 0.03a | 1.15 ± 0.13d |
| 12 | 4.62 ± 0.08e | 2.21 ± 0.38e | 0.03 ± 0.03ab | 4.7 ± 0d | 1.97 ± 0.34e |
| 13 | 0.79 ± 0.1c | 1.04 ± 0.14d | 1.83 ± 1.17cd | 0.51 ± 0.05b | 0.97 ± 0.07cd |
Note: Data are presented as means ± SEM of three replicates. Different alphabets indicate significantly different groupings following Duncan post hoc comparison of each column (p < 0.05). Relative expression (ΔΔCq) was calculated by normalizing to the reference gene (GAPDH) and negative controls
Concentrations (pg/ml) of immune-related proteins in the serum of FCoV-positive cats
| FIP Form | ID | Fas | Flt-3lL | GM-CSF | IFNγ | IL1β | IL2 | PDGF-BB | IL12/p40 | IL13 | IL4 | IL6 | IL8 | KC | SDF1 | RANTES | SCF | MCP1 | TNFα | IL18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NC | 1a | <8.3 ± 0 | 45.3 ± 1.4 | 8.3 ± 0.1 | 12.3 ± 0 | <17.3 ± 0 | 19.1 ± 0.2 | 300.1 ± 4.0 | 194.3 ± 5.3 | 5.6 ± 0 | 106.5 ± 1.7 | <36.3 ± 0 | 13.0 ± 0.2 | 3.7 ± 0.2 | 92 ± 1.4 | 8.4 | 118.3 ± 2.5 | 845.5 ± 0 | 115 ± 1.7 | <71.2 ± 0 |
| Dry | 2 | <8.3 ± 0 | 13.5 ± 0.2 | 7.6 ± 0.3 | 16.4 ± 0.2 | <17.3 ± 0 | 17.1 ± 0.5 | 297.5 ± 4.5 | 1269 ± 11.6 | 5.9 ± 0.2 | 124.7 ± 1.4 | <36.3 ± 0 | 32.6 ± 0.2 | 25.6 ± 0.9 | 64.8 ± 1 | 19.8 ± 0.1 | 49.0 ± 0.3 | 958 ± 12.5 | 65.0 ± 1.3 | <71.2 ± 0 |
| 3 | 9.8 ± 0.13 | 54.7 ± 1.7 | 15.0 ± 0.2 | 47.5 ± 0.4 | <17.3 ± 0 | 17.8 ± 0.9 | 333.2 ± 0 | 268.5 ± 6.5 | 8.5 ± 0.1 | 287.4 ± 2.8 | <36.3 ± 0 | 22.7 ± 0.5 | 25.7 ± 0.5 | 97.9 ± 0 | 19.3 ± 0.6 | 65.7 ± 2 | 1890 ± 0 | 152.3 ± 7.1 | 151.4 ± 9.8 | |
| 6 | 10.7 ± 0.1 | 24.9 ± 0.7 | 24.3 ± 0.1 | 39.2 ± 0.7 | 19 ± 0.94 | 24.8 ± 0 | 363.5 ± 3.3 | 147.6 ± 1.8 | 13.3 ± 0.4 | 323.2 ± 12.4 | <36.3 ± 0 | 28.0 ± 0.6 | 22.8 ± 1.0 | 117.7 ± 0 | 8.6 | 73.2 ± 2.3 | 1738 ± 41 | 104.28 ± 2 | 477.9 ± 5.7 | |
| Wet | 7 | 9.1 ± 0.3 | 27.3 ± 2.4 | 15.2 ± 0.5 | 43.2 ± 2.5 | <17.3 ± 0 | 17.8 ± 0.9 | 319.3 ± 8.1 | 543.9 ± 40.5 | 8.2 ± 0.3 | 117.3 ± 2.9 | <36.3 ± 0 | 17.8 ± 1.6 | 3.3 ± 0.5 | 96.4 ± 2.6 | 16.8 ± 1.7 | 39.2 ± 3.7 | 914 ± 12.9 | 59.3 ± 2 | <71.2 ± 0 |
| 8 | 8.9 ± 0.1 | 14.1 ± 0.1 | 27.0 ± 0.3 | 14.2 ± 0.2 | <17.3 ± 0 | 17.9 ± 0 | 339.6 ± 3.7 | 237.5 ± 0.5 | 6.2 ± 0 | 107.4 ± 2.9 | <36.3 ± 0 | 19 | 27.6 ± 0.7 | 85.9 ± 1.8 | 9.0 | <32.5 ± 0 | 868.6 ± 13.4 | 55 ± 0.5 | <71.2 ± 0 | |
| 9 | 9.2 ± 0 | 39.5 ± 1.1 | 20.2 ± 0.1 | 61.9 ± 1.4 | <17.3 ± 0 | 20.8 ± 0 | 332.8 ± 7.6 | 958.2 ± 36.8 | 7.8 ± 0 | 166.5 ± 0 | <36.3 ± 0 | 16.0 ± 0.3 | 45.3 ± 1.9 | 84.3 ± 0.9 | 11.7 ± 0.3 | 39.5 ± 0.9 | 914.1 ± 12.9 | 66.3 ± 0 | <71.2 ± 0 | |
| 5 | 11.5 ± 0.1 | 56.4 ± 0.1 | 16.2 ± 0.3 | 21.9 ± 0 | <17.3 ± 0 | 22.9 ± 0.4 | 333.2 ± 0 | 2923.5 ± 70.7 | 7.1 ± 0.1 | 139.5 ± 1.4 | <36.3 ± 0 | 28.9 ± 0.5 | 4.1 ± 0.1 | 90.5 ± 0.9 | 14.3 ± 0.1 | 46.6 ± 0.2 | 979.6 ± 0 | 88.8 ± 0 | <71.2 ± 0 | |
| 10 | 13.5 ± 0.3 | 44.2 ± 0.8 | 13.8 ± 0.2 | 85.6 ± 2.5 | 32.6 ± 0.3 | 22.2 ± 0 | 305.3 ± 0 | 564.8 ± 5.3 | 10.4 ± 0.2 | 420.4 ± 10.9 | 116.7 ± 7.1 | 29.3 ± 0.2 | 3.3 ± 0.2 | 90.4 ± 4.4 | 22.8 ± 0.3 | 76.5 ± 1.5 | 2379 ± 13.3 | 158.2 ± 6.1 | <71.2 ± 0 | |
| 11 | 12.6 ± 0 | 29.7 ± 0.9 | 19.1 ± 0.1 | 28.3 ± 1.2 | <17.3 ± 0 | 26.0 ± 0 | 385.2 ± 3.0 | 1131 ± 17.3 | 11.2 ± 0.2 | 187.2 ± 6.3 | <36.3 ± 0 | 37.6 ± 0.2 | 184.2 ± 7.0 | 189.3 ± 2.6 | 35.4 ± 0.6 | 69.2 ± 1.9 | 1082 ± 11.6 | 100 ± 2.5 | 96 ± 3.9 | |
| 12 | 12.2 ± 0 | 49.8 ± 1.7 | 11.1 ± 0.6 | 36.2 2.5 | 51.5 ± 6.9 | 95.3 ± 33.3 | 418.6 ± 5.2 | 655.1 ± 8.6 | 9.1 ± 0.3 | 294.4 ± 31.8 | 328.1 ± 56.2 | 28.9 ± 0.4 | 39.7 ± 34.8 | 303.9 ± 25.0 | 37.7 ± 0.4 | 48.9 ± 1.9 | 1370 ± 48.5 | 403.5 ± 40.6 | 522 ± 160.3 |
Note: Each sample was analyzed in three replicates and the data are expressed as means ± SEM
aAveraged concentrations from three healthy cats as negative controls (NC)
Concentrations (pg/ml) of immune-related proteins in the PES of FCoV-positive cats
| Cat ID | Fas | Flt-3lL | GM-CSF | IFNγ | IL1β | IL2 | PDGF-BB | IL12/p40 | IL13 | IL4 | IL6 | IL8 | KC | SDF1 | RANTES | SCF | MCP1 | TNFα | IL18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 12.8 ± 0.4 | 226.1 ± 15.6 | 18.1 ± 0.4 | 5157 ± 503.5 | 54.2 | 22.9 ± 0.4 | 357.5 ± 6.7 | 1033.6 ± 89.7 | 7.0 ± 0.2 | 125.9 ± 6.4 | 1123 ± 67.6 | 60.9 ± 5.5 | 4.9 ± 0.4 | 225.5 ± 3.1 | 650.5 ± 55.9 | 90.5 ± 3.1 | 968.7 ± 18.7 | 181.4 ± 2.4 | <71.2 ± 0 |
| 8 | 9.6 ± 0 | 15.5 ± 0.5 | 23.8 ± 0.7 | 60.9 ± 1.2 | 82.7 ± 2.3 | 19.4 ± 0 | 319.7 ± 0 | 1040.9 ± 56.1 | 6.0 ± 0.1 | 109.9 ± 1.4 | 424.0 ± 11.4 | 308.3 ± 10.8 | 7.6 ± 0.6 | 220.7 ± 4 | 34.1 ± 1.5 | 44.0 ± 0.6 | 868.6 ± 13.4 | 56.7 ± 0.5 | <71.2 ± 0 |
| 9 | 11.5 ± 0.4 | 218.3 ± 7.4 | 20.6 ± 0.3 | 5595 ± 250.6 | 54.8± 2.2 | 20.1± 0.4 | 345.5 ± 7.1 | 1598.5 ± 66.7 | 7.5 ± 0.2 | 149.3 ± 4.3 | 2998.5 ± 90.9 | 96.8 ± 3.3 | 12.1 ± 0.6 | 368.2 ± 14.3 | 180.1± 8.4 | 92.1± 2.9 | 968.7 ± 18.7 | 234.9 ± 9.1 | <71.2 ± 0 |
| 5 | 10.0 ± 0.3 | 159.1 ± 6.2 | 17.4 ± 0.2 | 21.5 ± 1.1 | 21.3 ± 1 | 21.5 ± 0.4 | 319.7 ± 0 | 690.7 ± 29.7 | 7.0 ± 0.2 | 112.3 ± 2.9 | 96.2 ± 14.9 | 76.2 ± 3.3 | 4.1 ± 0.4 | 314.4 ± 4.6 | 27.2± 1.1 | 36.9 ± 1.7 | 868.6 ± 13.4 | 67.2 ± 1.5 | <71.2 ± 0 |
| 10 | 11.1 ± 0.1 | 113.5 ± 1 | 15.9 ± 0.1 | 1072.5 ± 19.9 | 43.6 ± 0.5 | 20.1± 0.4 | 333.2 ± 0 | 908.8 ± 6.1 | 8.9 ± 0.1 | 382.6 ± 2.7 | 714.5 ± 1.4 | 86.8 ± 0.6 | 1.6 ± 0.1 | 372.4 ± 7.9 | 83.3 ± 0.7 | 82.8± 1 | 2228.5 ± 6.6 | 183.1 ± 0.5 | <71.2 ± 0 |
| 12 | 13.7 ± 0.1 | 121.7 ± 4.4 | 10.3 ± 0.1 | 170.0 ± 3.1 | 128.8 ± 5.7 | 201.2 ± 8.2 | 380 ± 0 | 582.9 ± 8.6 | 10.8 ± 0 | 523.8 ± 8.1 | 1302 ± 61.2 | 46.7 ± 1.5 | 22.0 ± 0.8 | 1679± 66.4 | 64.6 ± 2.3 | 52.4 ± 0.6 | 1371.5 ± 9.5 | 988.1 ± 41.5 | 1412.5 ± 58.6 |
| 13 | 25.0 ± 0.1 | 133.6 ± 0.6 | 11.7 ± 0 | 1888.5 ± 22.8 | 242.3 ± 1.8 | 45.2 ± 0.2 | 521.1 ± 3.5 | 3708.5 ± 11.3 | 13.4 ± 0.2 | 2000.5 ± 2.6 | 6736.5 ± 13 | 303.6 ± 3.6 | 3.4± 0.1 | 206.1 ± 0.6 | 411.6 ± 5.3 | 36.6± 0.4 | 1268.5 ± 10.1 | 942.7 ± 10.9 | 194.0 ± 1.9 |
Note: Each sample was analyzed in three replicates and the data are expressed as means ± SEM